Upon administration of cisplatin, PANDAR is transferred via exosomes, which aids ovarian cancer cells in rapidly adapting to cisplatin-induced stress through the accumulation of the serine and arginine-rich splicing factor 9 (SRSF9). Here, SRSF9 is linked to ovarian carcinoma.